Stay updated on Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial

Sign up to get notified when there's something new on the Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Footer revision updated from v3.3.3 to v3.3.4 with no other content changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:57:25.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Added a Locations section with Kentucky as a study site. Removed the Kentucky Locations entry and the HHS Vulnerability Disclosure link; revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T10:25:20.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.2, replacing Revision: v3.2.0. This is a metadata update and does not alter the study details.
    Difference
    0.1%
    Check dated 2025-11-24T17:49:46.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Removed the government funding/status notice related to NIH operations. The study details, eligibility criteria, and contact information on the page remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T17:33:54.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The update appears to adjust page layout and formatting without altering key study details such as eligibility, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T12:25:41.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice with operating status guidance for NIH Clinical Center and links to cc.nih.gov and opm.gov. - Updated version to v3.2.0. - Removed the previous v3.1.0 version tag.
    Difference
    5%
    Check dated 2025-10-05T16:44:34.000Z thumbnail image

Stay in the know with updates to Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial page.